abstract |
The present invention relates to exploring and developing pharmaceuticals, particularly novel pharmaceuticals for treating pancreatic diabetes. The present invention is based on the development of effective and low-toxic pharmaceuticals based on indole derivatives, which are conventionally used for anti-diabetic, lipid-lowering, hypoglycemic, cholesterol-lowering activity, and insulin resistance-improving actions. The structure is different from the structure of the compound. The indole derivatives of the present invention are even less toxic and are easily tolerated. |